Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways - PubMed
- ️Sun Jan 01 2006
Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways
ShouWei Han et al. Cancer Res. 2006.
Abstract
The Akt/mammalian target of rapamycin (mTOR)/ribosomal protein S6 kinase (p70S6K) pathway is considered a central regulator of protein synthesis and of cell proliferation, differentiation, and survival. However, the role of the Akt/mTOR/p70S6K pathway in lung carcinoma remains unknown. We previously showed that fibronectin, a matrix glycoprotein highly expressed in tobacco-related lung disease, stimulates non-small cell lung carcinoma (NSCLC) cell growth and survival. Herein, we explore the role of the Akt/mTOR/p70S6K pathway in fibronectin-induced NSCLC cell growth. We found that fibronectin stimulated the phosphorylation of Akt, an upstream inducer of mTOR, and induced the phosphorylation of p70S6K1 and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), two downstream targets of mTOR in NSCLC cells (H1792 and H1838), whereas it inhibited the phosphatase and tensin homologue deleted on chromosome 10, a tumor suppressor protein that antagonizes the phosphatidylinositol 3-kinase/Akt signal. In addition, treatment with fibronectin inhibited the mRNA and protein expression of LKB1 as well as the phosphorylation of AMP-activated protein kinase (AMPKalpha), both known to down-regulate mTOR. Rapamycin, an inhibitor of mTOR, blocked the fibronectin-induced phosphorylation of p70S6K and 4E-BP1. Akt small interfering RNA (siRNA) and an antibody against the fibronectin-binding integrin alpha5beta1 also blocked the p70S6K phosphorylation in response to fibronectin. In contrast, an inhibitor of extracellular signal-regulated kinase 1/2 (PD98095) had no effect on fibronectin-induced phosphorylation of p70S6K. Moreover, the combination of rapamycin and siRNA for Akt blocked fibronectin-induced cell proliferation. Taken together, these observations suggest that fibronectin-induced stimulation of NSCLC cell proliferation requires activation of the Akt/mTOR/p70S6K pathway and is associated with inhibition of LKB1/AMPK signaling.
Similar articles
-
Han S, Roman J. Han S, et al. Mol Cancer Ther. 2006 Feb;5(2):430-7. doi: 10.1158/1535-7163.MCT-05-0347. Mol Cancer Ther. 2006. PMID: 16505118
-
Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression.
Zheng Y, Ritzenthaler JD, Roman J, Han S. Zheng Y, et al. Am J Respir Cell Mol Biol. 2007 Dec;37(6):681-90. doi: 10.1165/rcmb.2007-0051OC. Epub 2007 Jun 28. Am J Respir Cell Mol Biol. 2007. PMID: 17600315
-
Sun SY, Rosenberg LM, Wang X, Zhou Z, Yue P, Fu H, Khuri FR. Sun SY, et al. Cancer Res. 2005 Aug 15;65(16):7052-8. doi: 10.1158/0008-5472.CAN-05-0917. Cancer Res. 2005. PMID: 16103051
-
Mammalian target of rapamycin inhibition as therapy for hematologic malignancies.
Panwalkar A, Verstovsek S, Giles FJ. Panwalkar A, et al. Cancer. 2004 Feb 15;100(4):657-66. doi: 10.1002/cncr.20026. Cancer. 2004. PMID: 14770419 Review.
-
Martelli AM, Evangelisti C, Chappell W, Abrams SL, Bäsecke J, Stivala F, Donia M, Fagone P, Nicoletti F, Libra M, Ruvolo V, Ruvolo P, Kempf CR, Steelman LS, McCubrey JA. Martelli AM, et al. Leukemia. 2011 Jul;25(7):1064-79. doi: 10.1038/leu.2011.46. Epub 2011 Mar 25. Leukemia. 2011. PMID: 21436840 Review.
Cited by
-
The Role of the ECM in Lung Cancer Dormancy and Outgrowth.
Parker AL, Cox TR. Parker AL, et al. Front Oncol. 2020 Sep 11;10:1766. doi: 10.3389/fonc.2020.01766. eCollection 2020. Front Oncol. 2020. PMID: 33014869 Free PMC article. Review.
-
alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer.
Roman J, Ritzenthaler JD, Roser-Page S, Sun X, Han S. Roman J, et al. Am J Respir Cell Mol Biol. 2010 Dec;43(6):684-91. doi: 10.1165/rcmb.2009-0375OC. Epub 2010 Jan 15. Am J Respir Cell Mol Biol. 2010. PMID: 20081050 Free PMC article.
-
Jia D, Yan M, Wang X, Hao X, Liang L, Liu L, Kong H, He X, Li J, Yao M. Jia D, et al. BMC Cancer. 2010 Jul 9;10:364. doi: 10.1186/1471-2407-10-364. BMC Cancer. 2010. PMID: 20615257 Free PMC article.
-
Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours.
Pulkka OP, Mpindi JP, Tynninen O, Nilsson B, Kallioniemi O, Sihto H, Joensuu H. Pulkka OP, et al. J Cell Mol Med. 2018 Apr;22(4):2220-2230. doi: 10.1111/jcmm.13502. Epub 2018 Jan 29. J Cell Mol Med. 2018. PMID: 29377440 Free PMC article.
-
Matrix control of pancreatic cancer: New insights into fibronectin signaling.
Topalovski M, Brekken RA. Topalovski M, et al. Cancer Lett. 2016 Oct 10;381(1):252-8. doi: 10.1016/j.canlet.2015.12.027. Epub 2015 Dec 29. Cancer Lett. 2016. PMID: 26742464 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous